Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© 2005 by Marcel Dekker. All Rights Reserved. Stroke medicine is an evolving specialty driven in part by the identification of effective emergent therapies as well as the realization that organized stroke care results in reduced patient mortality and morbidity. The publication of the National Institute of Neurological Disorders and Stroke (NINDS) trial demonstrated the benefit of tissue plasminogen activator (tPA), which has changed the outlook for eligible stroke patients and provided the opportunity for change in general acute stroke care [1]. Acute stroke services employing these therapies are now required to be time sensitive [2], which in turn means there is a need to develop seamless patient care from the point of onset to discharge.



Book title

Handbook of Cerebrovascular Diseases, Second Edition, Revised and Expanded

Publication Date



163 - 181